MENU

PTKFF Stock PT Kalba Farma TBK (PTKFF, $0.1) was a top quarterly gainer, rising +27.56%

A.I.dvisor
at Tickeron.com
Loading...
PTKFF - PT Kalba Farma TBK
Tickeron

Loading...

Price: $0.0958
Daily change: +$0.00285 (+3.07%)
Daily volume: 53K
3-month price change: +$0.0207 (+27.56%)
Capitalization: $4.1B
Industry: Pharmaceuticals: Major
PT Kalba Farma TBK (PTKFF, $0.1) was one of top quarterly gainers, jumping +2 to $0.1 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.

PTKFF's Stochastic Oscillator remains in oversold zone for 21 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Momentum Indicator moved above the 0 level on September 17, 2025. You may want to consider a long position or call options on PTKFF as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for PTKFF moved above the 200-day moving average on August 13, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 92 cases where PTKFF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

PTKFF moved below its 50-day moving average on September 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PTKFF crossed bearishly below the 50-day moving average on September 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.083) is normal, around the industry mean (9.454). P/E Ratio (13.781) is within average values for comparable stocks, (23.720). Projected Growth (PEG Ratio) (1.069) is also within normal values, averaging (1.758). Dividend Yield (0.035) settles around the average of (0.028) among similar stocks. P/S Ratio (1.410) is also within normal values, averaging (3.441).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PTKFF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTKFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
PTKFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Jalan Let. Jend. Suprapto Kav. 4
Phone
+62 2142873888
Employees
16551
Web
https://www.kalbe.co.id